Epilepsy, a chronic neurological disorder characterized by recurrent seizures, continues to be a significant challenge in the healthcare sector. However, recent developments in its management have brought hope to millions of patients worldwide. This article provides an update on these advancements.
The last decade has witnessed the introduction of several new antiepileptic drugs (AEDs). These drugs, including perampanel, lacosamide, and brivaracetam, offer better seizure control with fewer side effects. They have also been found to be effective in patients who are resistant to traditional AEDs.
Neuromodulation techniques such as Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS) have shown promising results in controlling seizures. These techniques involve the delivery of electrical impulses to specific areas of the brain to regulate abnormal electrical activity.
Surgical interventions remain a viable option for patients with drug-resistant epilepsy. Advances in neuroimaging have improved the identification of seizure foci, making surgery more precise and effective. Minimally invasive techniques such as laser interstitial thermal therapy (LITT) are gaining popularity due to their reduced morbidity and shorter recovery times.
Genetic testing has revolutionized the diagnosis and treatment of epilepsy. It allows for the identification of specific genetic mutations associated with certain types of epilepsy, enabling personalized treatment plans. This approach, known as precision medicine, has the potential to significantly improve patient outcomes.
In conclusion, the management of epilepsy has significantly evolved over the past decade. The introduction of new AEDs, neuromodulation techniques, advancements in surgical interventions, and the advent of genetic testing and precision medicine have all contributed to this progress. It is crucial for healthcare professionals to stay updated on these advancements to provide the best possible care to their patients.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation